First Pacific Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

First Pacific Advisors’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,626	Closed	-$28K	–	148
2015 Q2	$28K	Hold	23,626	–	–	﹤0.01%	118
2015 Q1	$25K	Hold	23,626	–	–	﹤0.01%	120
2014 Q4	$26K	Sell	23,626 -323,409	-93%	-$339K	﹤0.01%	122
2014 Q3	$375K	Hold	347,035	–	–	﹤0.01%	108
2014 Q2	$361K	Hold	347,035	–	–	﹤0.01%	111
2014 Q1	$357K	Hold	347,035	–	–	﹤0.01%	118
2013 Q4	$403K	Sell	347,035 -30,000	-8%	-$46.2K	﹤0.01%	112
2013 Q3	$633K	Sell	377,035 -2,791	-0.7%	-$5.16K	0.01%	103
2013 Q2	$760K	Buy	+379,826	New	+$1.11M	0.01%	102

Other funds holding ENZN

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

First Pacific Advisors's ENZN Position: Q3 2015 in Review

First Pacific Advisors sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2015, closing a stake of 23,626 shares — an estimated $28K sold.

First Pacific Advisors first reported a position in ENZN in Q2 2013 and held it in 9 quarters. The position peaked at $760K in Q2 2013. 53 funds tracked by Wall St. Rank hold ENZN as of Q3 2015.

First Pacific Advisors reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2015 after selling out during the quarter.
First Pacific Advisors sold 23,626 ENZON PHARMACEUTICALS INC shares in Q3 2015, an estimated $28K.
First Pacific Advisors first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 9 quarters.
First Pacific Advisors's ENZON PHARMACEUTICALS INC position peaked at $760K in Q2 2013.
53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2015.

Based on First Pacific Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.